These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
444 related articles for article (PubMed ID: 35691028)
1. Extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches. Pérez-Nadales E; Fernández-Ruiz M; Gutiérrez-Gutiérrez B; Pascual Á; Rodríguez-Baño J; Martínez-Martínez L; Aguado JM; Torre-Cisneros J Transpl Infect Dis; 2022 Aug; 24(4):e13881. PubMed ID: 35691028 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project). Pierrotti LC; Pérez-Nadales E; Fernández-Ruiz M; Gutiérrez-Gutiérrez B; Tan BH; Carratalà J; Oriol I; Paul M; Cohen-Sinai N; López-Medrano F; San-Juan R; Montejo M; Freire MP; Cordero E; David MD; Merino E; Mehta Steinke S; Grossi PA; Cano Á; Seminari EM; Valerio M; Gunseren F; Rana M; Mularoni A; Martín-Dávila P; van Delden C; Hamiyet Demirkaya M; Koçak Tufan Z; Loeches B; Iyer RN; Soldani F; Eriksson BM; Pilmis B; Rizzi M; Coussement J; Clemente WT; Roilides E; Pascual Á; Martínez-Martínez L; Rodríguez-Baño J; Torre-Cisneros J; Aguado JM; Transpl Infect Dis; 2021 Jun; 23(3):e13520. PubMed ID: 33222379 [TBL] [Abstract][Full Text] [Related]
3. Clinical prediction tool for extended-spectrum beta-lactamase-producing enterobacterales as the etiology of a bloodstream infection in solid organ transplant recipients. Wang R; Han JH; Lautenbach E; Tamma PD; Thom KA; Alby K; Blumberg EA; Bilker WB; Werzen A; Omorogbe J; Tolomeo P; Anesi JA Transpl Infect Dis; 2021 Aug; 23(4):e13599. PubMed ID: 33724633 [TBL] [Abstract][Full Text] [Related]
4. Multidrug-resistant Gram-negative infection in solid organ transplant recipients: implications for outcome and treatment. Silva JT; Fernández-Ruiz M; Aguado JM Curr Opin Infect Dis; 2018 Dec; 31(6):499-505. PubMed ID: 30299353 [TBL] [Abstract][Full Text] [Related]
5. Temporal trends, risk factors and outcomes of infections due to extended-spectrum β-lactamase producing Enterobacterales in Swiss solid organ transplant recipients between 2012 and 2018. Kohler P; Wolfensberger A; Stampf S; Brönnimann A; Boggian K; van Delden C; Favre M; Hirzel C; Khanna N; Kuster SP; Manuel O; Neofytos D; Ragozzino S; Schreiber PW; Walti L; Mueller NJ; Antimicrob Resist Infect Control; 2021 Mar; 10(1):50. PubMed ID: 33678189 [TBL] [Abstract][Full Text] [Related]
6. Impact of pre-transplant carbapenem-resistant Enterobacterales colonization and/or infection on solid organ transplant outcomes. Taimur S; Pouch SM; Zubizarreta N; Mazumdar M; Rana M; Patel G; Freire MP; Pellett Madan R; Kwak EJ; Blumberg E; Satlin MJ; Pisney L; Clemente WT; Zervos MJ; La Hoz RM; Huprikar S Clin Transplant; 2021 Apr; 35(4):e14239. PubMed ID: 33527453 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of multidrug-resistant gram-negative bacilli producing extended-spectrum β-lactamases (ESBLs) and ESBL genes in solid organ transplant recipients. Men TY; Wang JN; Li H; Gu Y; Xing TH; Peng ZH; Zhong L Transpl Infect Dis; 2013 Feb; 15(1):14-21. PubMed ID: 23013385 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of and risk factors for intestinal colonisation by multidrug-resistant Gram-negative bacteria in patients with haematological malignancies: A systematic review and meta-analysis. Luo H; Chen X; Jiang Z; Yan Q Int J Antimicrob Agents; 2024 Jan; 63(1):107043. PubMed ID: 38040318 [TBL] [Abstract][Full Text] [Related]
9. New drugs for difficult bugs: management of multidrug-resistant gram-negative infections in solid organ transplant recipients. Pouch SM Curr Opin Organ Transplant; 2021 Aug; 26(4):424-431. PubMed ID: 34148979 [TBL] [Abstract][Full Text] [Related]
10. Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales ("MERINO-3"): study protocol for a multicentre, open-label randomised non-inferiority trial. Stewart AG; Harris PNA; Chatfield MD; Littleford R; Paterson DL Trials; 2021 Apr; 22(1):301. PubMed ID: 33888139 [TBL] [Abstract][Full Text] [Related]
11. Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa). Tamma PD; Aitken SL; Bonomo RA; Mathers AJ; van Duin D; Clancy CJ Clin Infect Dis; 2021 Apr; 72(7):e169-e183. PubMed ID: 33106864 [TBL] [Abstract][Full Text] [Related]
12. Changing trends in the aetiology, treatment and outcomes of bloodstream infection occurring in the first year after solid organ transplantation: a single-centre prospective cohort study. Oriol I; Sabé N; Simonetti AF; Lladó L; Manonelles A; González J; Tubau F; Carratalà J Transpl Int; 2017 Sep; 30(9):903-913. PubMed ID: 28500792 [TBL] [Abstract][Full Text] [Related]
13. Extended-spectrum beta-lactamase-producing bacterial infections in adult solid organ transplant recipients. Winters HA; Parbhoo RK; Schafer JJ; Goff DA Ann Pharmacother; 2011 Mar; 45(3):309-16. PubMed ID: 21386016 [TBL] [Abstract][Full Text] [Related]
14. Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa). Tamma PD; Aitken SL; Bonomo RA; Mathers AJ; van Duin D; Clancy CJ Clin Infect Dis; 2022 Aug; 75(2):187-212. PubMed ID: 35439291 [TBL] [Abstract][Full Text] [Related]
15. Multidrug-resistant Enterobacterales infections in abdominal solid organ transplantation. Pilmis B; Weiss E; Scemla A; Le Monnier A; Grossi PA; Slavin MA; Van Delden C; Lortholary O; Paugam-Burtz C; Zahar JR Clin Microbiol Infect; 2023 Jan; 29(1):38-43. PubMed ID: 35716912 [TBL] [Abstract][Full Text] [Related]